Clinical Trial Update: Transplantation and the Use of Raltegravir in HIV-Infected Patients

View source ↗

Summary

Clinical trial completion update on the use of raltegravir in HIV-infected patients undergoing organ transplantation. The trial was sponsored by Duke University…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)

Snippet

Sponsor: Duke University | Conditions: HIV Positive, Organ Transplant Recipient | Status: COMPLETED